About   Help   FAQ
References
Query Results -- Details

MGI Accession ID: MGI:3771746
J Number: J:130467
Other Accession IDs: Title: Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.
Authors: Hanna J; Wernig M; Markoulaki S; Sun CW; Meissner A; Cassady JP; Beard C; Brambrink T; Wu LC; Townes TM; Jaenisch R
Journal: Science
Volume: 318
Issue: 5858
Date: 2007 Dec 21
Year: 2007
Pages: 1920-3
Review Status: Peer Reviewed

Abstract:

It has recently been demonstrated that mouse and human fibroblasts can be reprogrammed into an embryonic stem cell-like state by introducing combinations of four transcription factors. However, the therapeutic potential of such induced pluripotent stem (iPS) cells remained undefined. By using a humanized sickle cell anemia mouse model, we show that mice can be rescued after transplantation with hematopoietic progenitors obtained in vitro from autologous iPS cells. This was achieved after correction of the human sickle hemoglobin allele by gene-specific targeting. Our results provide proof of principle for using transcription factor-induced reprogramming combined with gene and cell therapy for disease treatment in mice. The problems associated with using retroviruses and oncogenes for reprogramming need to be resolved before iPS cells can be considered for human therapy.

Additional Information:

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
11/20/2009
MGI_4.31
Web browser compatibility
The Jackson Laboratory